Validation of the 'Suicidality: Treatment Occuring in Paediatrics (STOP) Suite of Measures' in Clinical and Non-clinical Child and Adolescent Populations
- Conditions
- Psychiatrische aandoeningen waarvoor een anti-psychoticum of anti-depressiva wordt voorgeschrevenPsychiatric disorder
- Registration Number
- NL-OMON38610
- Lead Sponsor
- niversitair Medisch Centrum Sint Radboud
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Withdrawn
- Sex
- Not specified
- Target Recruitment
- 250
Children and adolescents between the ages of 8 and 18 years old, and their parents or main carer.
Children and adolescents newly treated with an antidepressant or cognitive behavior therapy for depression or antipsychotic medication for any indication (this inclusion criteria is for clinical population only).
All parents and patients have provided informed consent/assent in accordance with ethical regulations.
If the main carer does not have a reasonable level of Dutch, they will be excluded from the study. This is because a reasonable level of Dutch is required to complete the baseline information.
Children who are deemed by the clinician to be too vulnerable to participate (for clinical population only).
The child/adolescent will be excluded if the main carer is not available to participate in the study.
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>The goal of this study is to develop a reliable and efficient screening tool<br /><br>for suicidal ideation and suicide risk in children and adolescents specifically<br /><br>addressed to capture the possible influence of medication side effects or<br /><br>mechanism of action. The rating scale will have one form for children and<br /><br>adolescents, one form to be addressed to their parents and another form to be<br /><br>completed by the clinician.</p><br>
- Secondary Outcome Measures
Name Time Method <p>More specifically, the objectives are:<br /><br>1. To design a rating scale for assessing suicidality in children and<br /><br>adolescents including developing different versions for children, parents, and<br /><br>clinicians<br /><br>2. To translate the rating scales into all the languages of the countries<br /><br>collaborating in the study and to carry out a first evaluation of the<br /><br>psychometric properties of the resulting scales.</p><br>